FDCDDQ
GMAB icon

Federation des caisses Desjardins du Quebec’s Genmab GMAB Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-50
Closed -$1.34K – 3077
2026
Q1 		$1.34K Hold
50
– – ﹤0.01% 2724
2025
Q4 		$1.54K Buy
+50
New +$1.56K ﹤0.01% 2631
2024
Q2 		– Sell
-33
Closed -$987 – 2522
2024
Q1 		$987 Sell
33
-182
-85% -$5.35K ﹤0.01% 2193
2023
Q4 		$6.85K Sell
215
-378
-64% -$11.9K ﹤0.01% 1842
2023
Q3 		$20.9K Sell
593
-72
-11% -$2.74K ﹤0.01% 1559
2023
Q2 		$25.3K Sell
665
-520
-44% -$20.7K ﹤0.01% 1519
2023
Q1 		$44.7K Buy
1,185
+935
+374% +$35.9K ﹤0.01% 1353
2022
Q4 		$10.6K Buy
+250
New +$10.3K ﹤0.01% 1862
2021
Q4 		– Sell
-200
Closed -$8.74K – 2545
2021
Q3 		$8.74K Buy
+200
New +$8.98K ﹤0.01% 2086

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's GMAB Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec sold out of Genmab (GMAB) in Q2 2026, closing a stake of 50 shares — an estimated $1.34K sold.

Federation des caisses Desjardins du Quebec first reported a position in GMAB in Q3 2021 and held it in 9 quarters. The position peaked at $44.7K in Q1 2023. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Federation des caisses Desjardins du Quebec reported no remaining Genmab position as of Q2 2026 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 50 Genmab shares in Q2 2026, an estimated $1.34K.
  • Federation des caisses Desjardins du Quebec first reported a position in Genmab in Q3 2021 and held it in 9 quarters.
  • Federation des caisses Desjardins du Quebec's Genmab position peaked at $44.7K in Q1 2023.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.